# Acetylsalicylic Acid

## Aspirin protect 100mg

| 藥物代碼           | OASP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Reducing the risk of mortality in patients with a suspected acute MI or a history of MI; secondary prevention of stroke; reducing the risk of transient ischaemic attacks (TIA) & stroke in patients with TIA; reducing the risk of morbidity & death in patients with stable & unstable angina pectoris; prevention of thromboembolism after vascular surgery or interventions (e.g. PTCA, CABG, carotid endarterectomy, arteriovenous shunts); prophylaxis of deep vein thrombosis & lung embolism after longer-term immobilisation (e.g. after major surgery); reducing the risk of first MI in patients with CV risk factors (e.g. diabetes mellitus, hyperlipidaemia, hypertension, obesity, smoking, old age). |
| 副作用             | Hypersensitivity reactions; GI disturbances; GI bleeding, ulceration or perforation; bleeding; dizziness & tinnitus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 禁忌               | Active peptic ulcers; haemorrhagic diathesis; a history of asthma induced by acetylsalicylic acid or other NSAIDs; combination with methotrexate at doses of ? 15 mg/week; last trimester of pregnancy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 用法用量           | Antipyretic & analgesic: Adult: 325-650 mg q4h as needed.  Child:10-15 mg/kg q4h. Arthritis:Adult:3.6-5.4 g/day.  Child: 65 mg/kg/day in divided doses q6h. Acute rheumatic fever: Up to 7.8 g/day. Transient ischemic attacks: 1300 mg/day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 肝功能異常         | 需 調 整 劑 量  Avoid use in severe liver disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 腎功能異常         | 需 調 整 劑 量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 孕期用藥建議       | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 附帶說明           | 1.Compatible (Low Dose) 40~150mg/day 2.PREGNANCY RECOMMENDATION: Human Data Suggest Risk in 1st and 3rd Trimesters (Full Dose)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

## Bokey 100mg

| 藥物代碼           | OBOK                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Reducing the risk of mortality in patients with a suspected acute MI or a history of MI; secondary prevention of stroke; reducing the risk of transient ischaemic attacks (TIA) & stroke in patients with TIA; reducing the risk of morbidity & death in patients with stable & unstable angina pectoris; prevention of thromboembolism after vascular surgery or interventions; prophylaxis of deep vein thrombosis & lung embolism after longer-term immobilisation; reducing the risk of first MI in patients with CV risk factors.                                                                                                                                                                                                                                                                        |
| 副作用             | Hypersensitivity reactions; GI disturbances; GI bleeding, ulceration or perforation; bleeding; dizziness & tinnitus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 禁忌               | Active peptic ulcers; haemorrhagic diathesis; a history of asthma induced by   acetylsalicylic acid or other NSAIDs; combination with methotrexate at doses of ? 15 mg/week; last trimester of pregnancy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量           | Antipyretic & analgesic: Adult: 325-650 mg q4h as needed.  Child:10-15 mg/kg q4h. Arthritis:Adult:3.6-5.4 g/day.  Child: 65 mg/kg/day in divided doses q6h. Acute rheumatic fever: Up to 7.8 g/day. Transient ischemic attacks: 1300 mg/day. Kawasaki disease(MCLS): Infants, Children, and Adolescents: Oral: 80 to 100 mg/kg/day divided every 6 hours for up to 14 days until fever resolves for at least 48 hours; then decrease dose to 1 to 5 mg/kg/day once daily (AHA and AAP suggest 3 to 5 mg/kg/day). Combine initial high-dose treatment with IV immune globulin (within first 10 days of symptom onset). In patients without coronary artery abnormalities, give lower dose for 6 to 8 weeks. In patients with coronary artery abnormalities, low-dose aspirin should be continued indefinitely. |
| 肝功能異常         | 需 調 整 劑 量  Avoid use in severe liver disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 腎功能異常         | 需 調 整 劑 量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 孕期用藥建議       | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 附帶說明           | 1.Compatible (Low Dose) 40~150mg/day 2.PREGNANCY RECOMMENDATION: Human Data Suggest Risk in 1st and 3rd Trimesters (Full Dose)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 注射劑給藥建議途徑 | PO                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

